The present invention relates to heart valve replacement and, in particular, to collapsible prosthetic heart valves. More particularly, the present invention relates to collapsible prosthetic heart valves having unique valve leaflet attachments.
Prosthetic heart valves that are collapsible to a relatively small circumferential size can be delivered into a patient less invasively than valves that are not collapsible. For example, a collapsible valve may be delivered into a patient via a tube-like delivery apparatus such as a catheter, a trocar, a laparoscopic instrument, or the like. This collapsibility can avoid the need for a more invasive procedure such as full open-chest, open-heart surgery.
Collapsible prosthetic heart valves typically take the form of a valve structure mounted on a stent. There are two common types of stents on which the valve structures are ordinarily mounted: a self-expanding stent and a balloon-expandable stent. To place such valves into a delivery apparatus and ultimately into a patient, the valve may first be collapsed or crimped to reduce its circumferential size and diameter.
When a collapsed prosthetic valve has reached the desired implant site in the patient (e.g., at or near the annulus of the patient's heart valve that is to be replaced by the prosthetic valve), the prosthetic valve can be deployed or released from the delivery apparatus and re-expanded to full operating use site. For balloon-expandable valves, this generally involves releasing the entire valve, assuring its proper location, and then expanding a balloon positioned within the valve stent. For self-expanding valves, on the other hand, the stent automatically expands as the sheath covering the valve is withdrawn.
In some embodiments, a prosthetic heart valve includes a stent extending in a longitudinal direction and having a plurality of commissure features; a valve assembly secured to the stent, the valve assembly including a cuff and a plurality of leaflets, each of the leaflets having a pair of attachment regions and a free edge extending between the attachment regions; and a deflection feature in an attachment region of a leaflet and configured and arranged to prevent the free edge of the leaflet from contacting at least one of the stent or the cuff.
In some embodiments, a prosthetic heart valve includes a stent having a collapsed condition and an expanded condition, the stent having a plurality of commissure features; a valve assembly secured to the stent, the valve assembly including a cuff and a plurality of leaflets, each of the leaflets having a pair of attachment regions and a free edge extending between the attachment regions; and at least one of a swatch of material, a leaflet tab and a cuff flap disposed adjacent the attachment regions and configured and arranged to prevent the free edge of one of the plurality of leaflets from contacting at least one of the stent or the cuff.
Various embodiments of the present invention are described herein with reference to the drawings, wherein:
Various embodiments of the present invention will now be described with reference to the appended drawings. It will be appreciated that these drawings depict only some embodiments of the invention and are therefore not to be considered limiting of its scope.
The present disclosure is directed to prosthetic heart valves having deflective features coupleable to at least one of a cuff and a leaflet to reduce and/or prevent abrasion of a leaflet as well as portions of the cuff and methods of making same. Such deflective features may modify the movement of the leaflets as will be explained in greater detail below. As used herein, the term “proximal,” when used in connection with a prosthetic heart valve, refers to the end of the heart valve closest to the heart when the heart valve is implanted in a patient, whereas the term “distal,” when used in connection with a prosthetic heart valve, refers to the end of the heart valve farthest from the heart when the heart valve is implanted in a patient. Also, as used herein, the words “substantially,” “generally” and “about” are intended to mean that slight variations from absolute are included within the scope of the structure or process recited.
The prosthetic heart valve 100 includes a stent or frame 102, which may be wholly or partly formed of any biocompatible material, such as metals, synthetic polymers, or biopolymers capable of functioning as a stent. Stent 102 is expandable and collapsible so that prosthetic heart valve 100 may be transitioned between a collapsed condition and an expanded condition. Suitable biopolymers include, but are not limited to, elastin, and mixtures or composites thereof. Suitable metals include, but are not limited to, cobalt, titanium, nickel, chromium, stainless steel, and alloys thereof, including nitinol. Suitable synthetic polymers for use as a stent include, but are not limited to, thermoplastics, such as polyolefins, polyesters, polyamides, polysulfones, acrylics, polyacrylonitriles, polyetheretherketone (PEEK), and polyaramides. The stent 102 may have an annulus section 110, an aortic section (not shown), and an intermediate section (not shown) disposed between the annulus and aortic sections. Each of the annulus section 110, the intermediate section, and the aortic section of the stent 102 includes a plurality of cells 112 connected to one another around the stent. The annulus section 110, the intermediate section, and the aortic section of the stent 102 may each include one or more annular rows of cells 112 connected to one another. For instance, the annulus section 110 may have two annular rows of cells 112. When the prosthetic heart valve 100 is in the expanded condition, each cell 112 may be substantially diamond shaped. Regardless of its shape, each cell 112 is formed by a plurality of struts 114. For example, a cell 112 may be formed by four struts 114.
The stent 102 may include commissure features or commissure posts (not shown) which may connect at least two cells 112 in the longitudinal direction of the stent 102. The commissure features may include eyelets that facilitate the suturing of a valve assembly and/or leaflets to the stent 102.
The prosthetic heart valve 100 also includes a valve assembly 104 attached inside the annulus section 110 of the stent 102. United States Patent Application Publication No. 2008/0228264 and United States Patent Application Publication No. 2008/0147179, the entire disclosures of both of which are hereby incorporated herein by reference, describe suitable valve assemblies. The valve assembly 104 may be wholly or partly formed of any suitable biological material, fabric or a polymer. Examples of biological materials suitable for the valve assembly 104 include, but are not limited to, porcine or bovine pericardial tissue. Examples of polymers suitable for the valve assembly 104 include, but are not limited to, fabric or polymers such as, polyurethane, ultra-high molecular weight polyethylene, polyethylene terephthalate and polyester.
The valve assembly 104 may include a cuff 106 disposed on the luminal surface of annulus section 110, on the abluminal surface of the annulus section, or on both surfaces, and the cuff may cover all or part of either or both of the luminal and abluminal surfaces of the annulus section.
The cuff 106 of the prosthetic heart valve 100 of
Instead of being formed of a single piece of material that is folded as shown in
Instead of having one or more separately formed swatches attached to the leaflets to limit the range of motion of the free edges, the leaflets may be formed with integrated deflection features. Without being bound to any particular theory, the integrated deflection features may limit the deflection of the leaflet free edge in several ways. For example, the deflection features may provide increased bulk and/or stiffness at certain regions (e.g., adjacent commissure features) so as to radially space the free edge of leaflets away from the stent and/or calcium nodules and reduce deflection of the leaflet, thereby preventing abrasion at portions of the leaflet and/or cuff. Alternatively, the integrated deflection features may shorten the length of the free edge that is capable of deflection, thereby limiting the amount of deflection.
Several variations of leaflet attachment regions are described with reference to
In
In a third variation, shown in
In addition to tabs and/or segments formed on the leaflet, bulk and/or stiffness may be added adjacent the attachment regions of a leaflet by modifying the cuff.
Cuff 706 may include a plurality of flaps adjacent commissure features 714 for added bulk. A first example is L-shaped flap 720a, which extends laterally from behind commissure feature 714a. Only a single L-shaped flap 720a is shown, though it will be understood that each commissure feature 714 may be flanked by two symmetric or dissimilar L-shaped flaps. Adjacent second commissure feature 714b are flaps 720b configured as rectangular segments projecting laterally away from the commissure feature. Diagonal flaps 720c and a triangular flap 720d are disposed adjacent commissure feature 714c. It will be understood that any combination of these flaps may be formed at any combination of commissure features 714 or at all of the commissure features. Additionally, it will be understood that flaps 720 may be integrally formed with cuff 706 or may be separately formed and subsequently attached to cuff 706 using sutures, adhesive or any other suitable coupling method.
Two methods of using cuff flaps to redirect the leaflet motion are shown in
In operation, any of the embodiments of the prosthetic heart valve described above may be used to replace a native heart valve, such as the aortic valve. The prosthetic heart valve may be delivered to the desired site in a patient (e.g., near a native aortic annulus) in a collapsed condition using any suitable delivery device. The delivery device may be introduced into the patient using a transfemoral, transapical, transseptal, transradial, transaortic, transsubclavian or other percutaneous approach. Once the delivery device has reached the target site, the user may deploy the prosthetic heart valve. Upon deployment, the prosthetic heart valve expands into secure engagement within the native valve annulus. When the prosthetic heart valve has been properly positioned inside the heart, it works as a one-way valve, allowing blood to flow in one direction and preventing blood from flowing in the opposite direction. Swatches, leaflet tabs or cuff flaps may restrict the movement of a leaflet to reduce contact between the leaflet and other portions (e.g., stent and/or cuff) of the heart valve when opening and closing, thereby reducing the risk of abrasion of the leaflet.
Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. For example, a prosthetic heart valve may include individual swatches, leaflet tabs, cuff flap or any suitable combination of the three. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims.
In some embodiments, a prosthetic heart valve includes a stent extending in a longitudinal direction and having a plurality of commissure features, a collapsed condition and an expanded condition; a valve assembly secured to the stent, the valve assembly including a cuff and a plurality of leaflets, each of the leaflets having a pair of attachment regions and a free edge extending between the attachment regions; and a deflection feature in an attachment region of a leaflet and configured and arranged to prevent the free edge of the leaflet from contacting at least one of the stent or the cuff.
In some examples, the deflection feature includes a swatch of material coupled to the attachment region, the material being selected from a group consisting of a fabric, a tissue and a polymer, and/or the swatch of material is folded over the free edges of two of the leaflets, and/or the swatch of material includes a pair of lobes joined to one another by a tailored neck, the tailored neck being folded over the free edges of the two leaflets, and/or the leaflet has an inner surface and an outer surface and the swatch of material includes two symmetric wings, each wing being coupled to one of the surfaces of the leaflet, and/or each wing has a quadrilateral shape, and/or the deflection feature includes an enlarged rectangular attachment region rolled on itself about an axis extending in the longitudinal direction to form a coil, and/or the deflection feature includes a leaflet tab connected to the attachment region of the leaflet, and/or the leaflet tab has a rectangular shape and is folded over the attachment region along a fold line extending substantially in the longitudinal direction, and/or the leaflet tab has a rectangular shape, the leaflet tab being folded on itself along a first fold line extending in a direction substantially orthogonal to the longitudinal direction and being folded over the attachment region along a second fold line extending substantially in the longitudinal direction, and/or the leaflet tab has equally an L-shape and is folded over the attachment region along fold lines extending substantially in the longitudinal direction and in a direction substantially orthogonal to the longitudinal direction, and/or the leaflet tab has generally an S-shape and is folded over the attachment region along fold lines extending substantially in the longitudinal direction and in a direction substantially orthogonal to the longitudinal direction, and/or the deflection feature includes a flap coupled to the cuff adjacent to each of the commissure features, and/or the flap has generally an L-shape, a rectangular shape, or a triangular shape, and/or the flap is folded on itself, and/or the flap is rolled on itself to form a cushion, and/or the flap is coupled to at least one of the plurality of leaflets.
In some embodiments, a prosthetic heart valve includes a stent having a collapsed condition and an expanded condition, the stent having a plurality of commissure features; a valve assembly secured to the stent, the valve assembly including a cuff and a plurality of leaflets, each of the leaflets having a pair of attachment regions and a free edge extending between the attachment regions; and at least one of a swatch of material, a leaflet tab and a cuff flap disposed adjacent the attachment regions and configured and arranged to prevent the free edge of one of the plurality of leaflets from contacting at least one of the stent or the cuff.
It will be appreciated that the various dependent claims and the features set forth therein can be combined in different ways than presented in the initial claims. It will also be appreciated that the features described in connection with individual embodiments may be shared with others of the described embodiments.
This application is a continuation of U.S. patent application Ser. No. 14/662,475, filed Mar. 19, 2015, which claims the benefit of the filing date of U.S. Provisional Patent Application No. 61/968,527 filed Mar. 21, 2014, the disclosure of which is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
4275469 | Gabbay | Jun 1981 | A |
4491986 | Gabbay | Jan 1985 | A |
4759758 | Gabbay | Jul 1988 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5411552 | Andersen et al. | May 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5843167 | Dwyer et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5935163 | Gabbay | Aug 1999 | A |
5961549 | Nguyen et al. | Oct 1999 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6083257 | Taylor et al. | Jul 2000 | A |
6090140 | Gabbay | Jul 2000 | A |
6214036 | Letendre et al. | Apr 2001 | B1 |
6264691 | Gabbay | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6368348 | Gabbay | Apr 2002 | B1 |
6419695 | Gabbay | Jul 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6488702 | Besselink | Dec 2002 | B1 |
6517576 | Gabbay | Feb 2003 | B2 |
6533810 | Hankh et al. | Mar 2003 | B2 |
6582464 | Gabbay | Jun 2003 | B2 |
6610088 | Gabbay | Aug 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6685625 | Gabbay | Feb 2004 | B2 |
6719789 | Cox | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6783556 | Gabbay | Aug 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6869444 | Gabbay | Mar 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7137184 | Schreck | Nov 2006 | B2 |
7160322 | Gabbay | Jan 2007 | B2 |
7247167 | Gabbay | Jul 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7311730 | Gabbay | Dec 2007 | B2 |
7374573 | Gabbay | May 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7524331 | Birdsall | Apr 2009 | B2 |
RE40816 | Taylor et al. | Jun 2009 | E |
7585321 | Cribier | Sep 2009 | B2 |
7682390 | Seguin | Mar 2010 | B2 |
7731742 | Schlick et al. | Jun 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7846204 | Letac et al. | Dec 2010 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
D648854 | Braido | Nov 2011 | S |
D652926 | Braido | Jan 2012 | S |
D652927 | Braido et al. | Jan 2012 | S |
D653341 | Braido et al. | Jan 2012 | S |
D653342 | Braido et al. | Jan 2012 | S |
D653343 | Ness et al. | Jan 2012 | S |
D654169 | Braido | Feb 2012 | S |
D654170 | Braido et al. | Feb 2012 | S |
D660432 | Braido | May 2012 | S |
D660433 | Braido et al. | May 2012 | S |
D660967 | Braido et al. | May 2012 | S |
D684692 | Braido | Jun 2013 | S |
20020036220 | Gabbay | Mar 2002 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20060008497 | Gabbay | Jan 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060173532 | Flagle et al. | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060206202 | Bonhoeffer et al. | Sep 2006 | A1 |
20060241744 | Beith | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060259120 | Vongphakdy et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060276813 | Greenberg | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070027534 | Bergheim et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070055358 | Krolik et al. | Mar 2007 | A1 |
20070067029 | Gabbay | Mar 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070100435 | Case et al. | May 2007 | A1 |
20070118210 | Pinchuk | May 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244552 | Salahieh et al. | Oct 2007 | A1 |
20070288087 | Fearnot et al. | Dec 2007 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082164 | Friedman | Apr 2008 | A1 |
20080097595 | Gabbay | Apr 2008 | A1 |
20080114452 | Gabbay | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255662 | Stacchino et al. | Oct 2008 | A1 |
20080262602 | Wilk et al. | Oct 2008 | A1 |
20080269879 | Sathe et al. | Oct 2008 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100049306 | House et al. | Feb 2010 | A1 |
20100087907 | Lattouf | Apr 2010 | A1 |
20100131055 | Case et al. | May 2010 | A1 |
20100168778 | Braido | Jul 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100204785 | Alkhatib | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20120197391 | Alkhatib et al. | Aug 2012 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
Number | Date | Country |
---|---|---|
19857887 | May 2005 | DE |
10121210 | Nov 2005 | DE |
202008009610 | Dec 2008 | DE |
0850607 | Jul 1998 | EP |
1000590 | May 2000 | EP |
1584306 | Oct 2005 | EP |
1598031 | Nov 2005 | EP |
1360942 | Dec 2005 | EP |
1926455 | Jun 2008 | EP |
2850008 | Jul 2004 | FR |
2847800 | Oct 2005 | FR |
9117720 | Nov 1991 | WO |
9716133 | May 1997 | WO |
9832412 | Jul 1998 | WO |
9913801 | Mar 1999 | WO |
0128459 | Apr 2001 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0156500 | Aug 2001 | WO |
0176510 | Oct 2001 | WO |
0236048 | May 2002 | WO |
0247575 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
06073626 | Jul 2006 | WO |
07071436 | Jun 2007 | WO |
08070797 | Jun 2008 | WO |
2009149462 | Dec 2009 | WO |
2010008548 | Jan 2010 | WO |
2010008549 | Jan 2010 | WO |
2010096176 | Aug 2010 | WO |
2010098857 | Sep 2010 | WO |
2012048035 | Apr 2012 | WO |
Entry |
---|
Catheter-implanted prosthetic heart valves, Knudsen, L.L., et al., The International Journal of Artificial Organs, vol. 16, No. 5 1993, pp. 253-262. |
Transluminal Aortic Valve Placement, Moazami, Nader, et al., ASAIO Journal, 1996; 42:M381-M385. |
Andersen, Henning Rud, Transluminal Catheter Implanted Prosthetic Heart Valves, International Journal of Angiology 7:102-106 (1998). |
Transluminal implantation of artificial heart valves, Andersen, H. R., et al., European Heart Journal (1992) 13, 704-708. |
Is It Reasonable to Treat All Calcified Stenotic Aortic Valves With a Valved Stent?, 579-584, Zegdi, Rachid, MD, PhD et al., J. of the American College of Cardiology, vol. 51, No. 5, Feb. 5, 2008. |
U.S. Appl. No. 29/375,243, filed Sep. 20, 2010. |
U.S. Appl. No. 29/375,260, filed Sep. 20, 2010. |
Ruiz, Carlos, Overview of PRE-CE Mark Transcatheter Aortic Valve Technologies, Euro PCR, 2010. |
Percutaneous aortic valve replacement: resection before implantation, 836-840, Quaden, Rene et al., European J. of Cardio-thoracic Surgery, 27 (2005). |
International Search Report and Written Opinion for Application No. PCT/US2015/021378 dated Aug. 4, 2015. |
Number | Date | Country | |
---|---|---|---|
20170143479 A1 | May 2017 | US |
Number | Date | Country | |
---|---|---|---|
61968527 | Mar 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14662475 | Mar 2015 | US |
Child | 15424991 | US |